Mucosal integrity

Mucosal integrity is a broad physiological concept referring to the structural and functional health of the mucous membranes, particularly in the gastrointestinal, respiratory, and urogenital tracts. It is not a single molecular target but a multi-layered defense system comprising a physical mucus layer, a selective epithelial cell barrier (maintained by tight junction proteins like claudins and occludins), and a robust underlying immune system [Source: NIH, PubMed]. This integrity is essential for preventing the translocation of pathogens and toxins into the systemic circulation while allowing for the absorption of nutrients and water. Disruption of this barrier, often referred to as 'leaky gut' in clinical contexts, is a key driver in the pathogenesis of inflammatory bowel disease (IBD) and peptic ulcers, where chronic inflammation prevents tissue repair [Source: Mayo Clinic]. Therapeutic interventions aimed at restoring mucosal integrity range from cytoprotective agents that coat the lining to pharmacological agonists that stimulate the natural regenerative processes of the epithelium. In drug development, 'mucosal healing' is often a secondary endpoint for treatments targeting specific cytokines or growth factor receptors, reflecting the restoration of this critical physiological state.

Other names

Mucosal barrier functionIntestinal barrier integrityEpithelial barrierGastrointestinal mucosal integrity

Restoration of mucosal integrity is achieved by stimulating prostaglandin synthesis to increase mucus and bicarbonate secretion (e.g., Misoprostol), providing physical cytoprotection (e.g., Sucralfate), or activating GLP-2 receptors to promote epithelial growth and tighten intercellular junctions (e.g., Teduglutide) [Source: StatPearls, PMCID: PMC6356951].